34892
Last Update Posted: 2013-01-04
Recruiting has ended
All Genders accepted | 16 Years-40 Years |
Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
CAFE Comparison of Atypicals in First Episode of Psychosis
The purpose of this study is to compare the effectiveness, tolerability, and efficacy of the currently available atypical antipsychotic drugs olanzapine (2.5-20 mg/day), quetiapine (100-800 mg/day) and risperidone (0.5-4 mg/day) in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder who are experiencing their first psychotic episode.
Eligibility
Relevant conditions:
Schizophrenia
Psychotic Disorders
Mental Health
Mental Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov